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chemmodlab: A Cheminformatics
Modeling Laboratory for Fitting and
Assessing Machine Learning Models
by Jeremy R. Ash, Jacqueline M. Hughes-Oliver
Abstract The goal of chemmodlab is to streamline the fitting and assessment pipeline for many
machine learning models in R, making it easy for researchers to compare the utility of new models.
While focused on implementing methods for model fitting and assessment that have been accepted
by experts in the cheminformatics field, all of the methods in chemmodlab have broad utility for
the machine learning community. chemmodlab contains several assessment utilities including a
plotting function that constructs accumulation curves and a function that computes many performance
measures. The most novel feature of chemmodlab is the ease with which statistically significant
performance differences for many machine learning models is presented by means of the multiple
comparisons similarity plot. Differences are assessed using repeated k-fold cross validation where
blocking increases precision and multiplicity adjustments are applied.
Introduction
It is now commonplace for researchers across a variety of fields to fit machine learning models on
complex data to make predictions. The complexity of these data (e.g., large number of features, non-
linear relationships with the response) often means it is difficult to determine a priori what machine
learning modeling routine and what descriptors (also known as features, predictors, or covariates)
will result in the best performance. A common approach to this problem is to fit many descriptor set
and modeling routine (D-M) combinations, and then compute measures of prediction performance for
held out data to choose a D-M combination by assessing relative performance.
Often in a particular domain, there are only a few modeling routines that are widely accepted, and
researchers tend to use these methods exclusively. Unfortunately, this will not always work well for
every data set and researchers might learn from other fields where different modeling methods tend to
be more succesful. There are a myraid of modeling methods implemented in R that may be worthwhile
for researchers to try (see Hastie et al. (2009) and Kuhn and Johnson (2013) for an overview of these
methods). However, the lack of knowledge of the syntactic minutiae and statistical methodology that
is required to fit and compare different modeling routines in R often prohibits users from attempting
them.
chemmodlab currently implements 13 different machine learning models. Fitting the entire suite
of models requires little user intervention – all models are fit with a single command. Sensible defaults
for tuning parameters are set automatically, but users may also tune models outside of chemmodlab
(in caret (Kuhn, 2008; from Jed Wing et al., 2016), for example) and then manually set the tuning
parameters.
While the package caret has a similar goal, the fitting of many D-M combinations and the de-
termination of statistically significant performance differences still requires some knowledge of R
programming and statistical methods. chemmodlab further automates this process and provides
several plotting utilities for easily assessing the results, lowering the barrier of entry for researchers
unfamiliar with these methods.
One motivation for this package was the observation that once performance measures are com-
puted for several different D-M combinations, researchers often do not consider the randomness and
uncertainity involved in obtaining the observed performance measures. If one model has prediction
performance that is marginally better than another, it is tempting to claim improvement. However,
very slight changes in the original data set or in how assessment was conducted could have led to a
reversal of observed performance. By accounting for the inherent uncertainity in data collection and
model assessment, a stronger and more defensible claim can be made about differences in prediction
performance. For example, a carefully constructed confidence interval that does not contain zero
for the difference in performance measures between two D-M combinations would reliably identify
significant differences between the two D-M combinations, even after accounting for uncertainty.
Figure 1 shows an example of this. Many classification models have been fit to two different
descriptor sets to predict a binary response variable. There are a total of 18 D-M combinations to
be compared. The D-M combinations were assessed using repeated 10-fold cross validation and
the area under the receiver operating characteristic curve (AUC) performance measure. A multiple
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         p−val<.01;  0.01 ≤ α
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0.05 ≤ p−val<.10;    0.1 ≤ α
  0.1 ≤ p−val<.90;    0.9 ≤ α      
  0.9 ≤ p−val<1
Multiplicity−adjusted p−values;
QSAR models different at level α  
Figure 1: MCS plot using area under the receiver operating characteristic curve as the performance
measure.
comparisons (MCS) plot visualizes the differences in model performance (Figure 1). The descriptor
sets will be discussed in detail later on, but for now, it is sufficient to say that the Pharmacophore
descriptors are far more interpretable than the Burden Number descriptors. The Burden Numbers-
Random Forest (RF) combination is the best performing D-M combination (AUC: .76). However, the
Pharmacophore-Least Angle Regression (LAR) combination (AUC: .71) involves a highly interpretable
linear model with a subset of the Pharmacophore descriptors selected. This .05 difference is small and
without additional investigations it is unclear whether it is statistically significant.
By performing multiple cross validation splits and using these splits as a blocking factor to improve
precision, chemmodlab is able to test for statistical significance of performance measure differences
and visualizes these results in a manner that can be easily interpreted by the user. The question this
addresses is: if the experiment were repeated with changes to the training and/or test set, would
the best performing model still be the best? Again referring to Figure 1, the MCS plot indicates that
a significance level of 0.01 leads to the conclusion that the two aformentioned D-M combinations
(Burden Numbers-RF, and Pharmacophores-LAR) are equivalent, and hence the more interpretable
model may be selected for further investigations. This inference has been multiplicity-adjusted for the
(182 ) = 153 pairwise comparisons that were made.
chemmodlab is a re-creation and extension of the former ChemModLab webserver (Hughes-Oliver
et al., 2011). Some notable extensions to the previous software are:
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• chemmodlab has been redesigned so that it is usable in the R environment. Models are fit with
a simple command, producing an object that can be easily passed to plotting and performance
assessment functions;
• much more control over the model fitting and assessment functions. There are now many argu-
ments for customizing the procedures and the output they provide, including the appearance of
the plots generated. As an example, chemmodlab now has support for user supplied tuning
parameters so that models can be better fit to the data at hand;
• and many new model performance measures for classification and regression have been imple-
mented.
chemmodlab is organized into two successive components: (1) model fitting, which is primarily
conducted via function ModelTrain and (2) model assessment, which is conducted via function
CombineSplits.
An illustrative example
Preparing the data
We will use a cheminformatics data set to illustrate a typical analysis pipeline in chemmodlab. In
cheminformatics, chemists often build machine learning models that relate a chemical compound’s
structure to an observed endpoint. These models are collectively referred to as quantitative structure-
activity relationship (QSAR) models. See Cherkasov et al. (2014) for an excellent review of the ways in
which these models have played a crucial role in the drug discovery process. Often the “endpoint”
(or response variable) is a measure of a compound’s biological activity, which may be either binary,
indicating active/inactive, or a continuous measure of binding affinity for a target protein. Chemical
descriptors represent various levels of organization of a chemical’s structure. See Cherkasov et al.
(2014) for an overview of commonly used chemical descriptors.
The data we will analyze is from a cytotoxicity assay conducted by the Scripps Research Institute
Molecular Screening Center. There are 3,311 compounds, 50 of which are active. Visit http://pubchem.
ncbi.nlm.nih.gov/assay/assay.cgi?aid=364 for more details, though this data set has been slightly
edited since we downloaded the version used here.
For completeness, the preprocessing of the data set analyzed will be shown. First, the response
variable and molecule IDs are read in from file.
aid364 <- read.csv("AID_364_response.csv")
head(aid364)
#> CID Outcome
#> 1 5388992 1
#> 2 5388983 1
#> 3 663143 1
#> 4 10607 1
#> 5 5388972 1
#> 6 11970251 1
Next, two descriptor sets are added to the data frame. Both of these sets were computed using
the software PowerMV - see Liu et al. (2005) for more information. The first set of 24 continuous
descriptors are a modification of the Burden number descriptors (Burden, 1989).
desc.lengths <- c()
d <- read.csv("BurdenNumbers.csv")
head(d[, 1:5])
#> Row WBN_GC_L_0.25 WBN_GC_H_0.25 WBN_GC_L_0.50 WBN_GC_H_0.50
#> 1 5388992 -2.40010 1.98339 -2.52864 2.50835
#> 2 5388983 -2.40010 1.98240 -2.52868 2.50398
#> 3 663143 -2.41650 1.32890 -2.53910 2.05778
#> 4 10607 -2.38337 2.17677 -2.52643 2.33232
#> 5 5388972 -2.29039 1.97468 -2.41743 2.46177
#> 6 11970251 -2.29039 2.22488 -2.41748 2.56161
aid364 <- merge(aid364, d, by.x = "CID", by.y = "Row")
desc.lengths <- c(desc.lengths, ncol(d[-1]))
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The number of descriptors in each descriptor set are also stored, as this information will be used
to parse the data frame later on. The second set contains 147 binary descriptors, indicating the
presence/absence of “pharmacophore” features, described in more detail in Liu et al. (2005).
d <- read.csv("Pharmacophores.csv")
head(d[, 1:6])
#> Row NEG_01_NEG NEG_02_NEG NEG_03_NEG NEG_04_NEG NEG_05_NEG
#> 1 5388992 0 0 0 0 0
#> 2 5388983 0 0 0 0 0
#> 3 663143 0 0 0 0 0
#> 4 10607 0 0 0 0 0
#> 5 5388972 0 0 0 0 0
#> 6 11970251 0 0 0 0 0
aid364 <- merge(aid364, d, by.x = "CID", by.y = "Row")
desc.lengths <- c(desc.lengths, ncol(d[-1]))
A subset of this data set, containing all 50 active compounds and an additional 450 compounds, is
included in chemmodlab.
Model fitting
The ModelTrain function
For the model fitting component of chemmodlab, the primary function is ModelTrain, which fits a
series of classification or regression models to a data set.
Function ModelTrain takes as input a data frame with an (optional) ID column, a response column,
and descriptor columns. We have processed the aid364 data set so that it follows this format. The
specification of an ID column allows users to easily match response predictions to their observation
IDs in the chemmodlab output.
chemmodlab can currently handle responses that are continuous or binary (represented as a
numeric vector with 0 or 1 values). Assessment assumes preference for large response values. Users
can specify which columns in the data frame they would like to consider as distinct descriptor sets. At
the moment, the response and descriptors may only be binary or continuous, though we are currently
working on support for categorical variables of more than two levels.
For our example, we previously stored the number of descriptors in each descriptor set in an
integer vector named desc.lengths, with the ordering of the integers matching the order of the
descriptor sets in aid364:
desc.lengths
#> [1] 24 147
Users can also name the descriptor sets by providing a character vector to the des.names argument.
If this character vector is specified, all of ModelTrain output and downstream chemmodlab functions
will name the descriptor sets accordingly:
des.names = c("BurdenNumbers", "Pharmacophores")
The specification of distinct descriptor sets in a data frame is illustrated in the following call to
ModelTrain:
cml <- ModelTrain(d = aid364, ids = TRUE, xcol.lengths = desc.lengths,
des.names = des.names, nfolds = 10, nsplits = 3,
seed.in = c(11111, 22222, 33333))
The nsplits argument sets the number of splits to use for repeated cross validation and nfolds
sets the number of folds to use for each cross validation split. The default values have been used.
seed.in sets the seeds used to randomly assign folds to observations for each repeated cross-validation
split. If NA, the first seed will be 11111, the second will be 22222, and so on.
If the descriptor set columns are not identified by the user, ModelTrain assumes there is one
descriptor set, namely all columns in d except the response column and optional ID column. Alter-
natively, the argument xcols may be used to explicitly specify the columns corresponding to each
descriptor set. Also, if it is more convenient, descriptor sets can be provided as a list of matrices with
the argument x and the response as a numeric vector with the argument y.
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chemmodlab models
Currently, 13 different machine learning models are implemented in chemmodlab. The details of
each modeling method, including descriptions of the default parameters, are provided at https://
jrash.github.io/chemmodlab/. Briefly, the current models are: elastic net (ENet), k-nearest neighbors
(KNN), lasso (Lasso), least angle regression (LAR), neural networks (NNet), partial least squares linear
discriminant analysis (PLSLDA), partial least squares (PLS), principal components regression (PCR),
ridge regression (Ridge), random forest (RF), two implementations of recursive partitioning (Tree,
RPart), and support vector machines (SVM).
These models have been carefully chosen to provide good coverage of the spectrum of model
flexibility and interpretability available for models implemented in R. Typically, models that are more
flexible (e.g., NNet) are capable of fitting more complex relationships between predictors and response,
but suffer in terms of model interpretability relative to other less flexible models (e.g., Lasso). By testing
for the significant differences between model performance measures, we hope to find interpretable
models whose performance is not significantly different from (i.e., plausibly equivalent to) the best
model, suggesting a model that provides an understanding of the relationship between the predictors
and response that exceeds mere prediction.
Some modeling strategies may not be suitable for both binary and continous responses. Six of
the models have implementations in R that directly support both binary and continuous responses
(Tree, RPart, RF, KNN, NNet, and SVM). However, six methods (Lasso, LAR, Ridge, ENet, PCR, and
PLS) assume that responses have equal variances and normal distributions. This assumption is often
reasonable for continuous responses, but may be suspect if the response is binary. For these latter six
methods, binary responses are treated as continuous, resulting in continuous response predictions
that are not restricted to range between 0 and 1. A threshold can then be applied to obtain a binary
predicted response. The model assessment functions discussed later allow users to select this threshold.
Finally, PLSLDA cannot be applied to a continous response, but if the user wishes to analyze this type
of data, a threshold value may be used to convert a continuous response to a binary one.
In cheminformatics applications, descriptors often show strong multicollinearity. Since this is
often problematic for machine learning models, we have specifically included several models in
chemmodlab that are known to be resilient to multicollinearity (e.g., PCR and PLS). However, with
the exception of PCR, which utilizes uncorrelated linear combinations of the original descriptors
and is a highly interpretable model, models for which prediction is not considerably affected by
multicollinearity do suffer in terms of model interpretability. For example, when one variable of a
set of highly positively correlated variables is selected for inclusion in the Lasso linear model, the
selection of the variable is essentially aribitrary. Fitting the same Lasso model to a slightly different
data set would likely result in the selection of a different variable from the same set.
chemmodlab has been designed in a way that it is easily extensible to new machine learning
modeling methods, and new modeling methods will be added as the authors identify those that have
broad utility to our users. Support for other models can be requested here: https://github.com/
jrash/chemmodlab/issues.
chemmodlab automatically performs data preprocessing before fitting the models that require it
(e.g., centering and scaling variables before PCR), so the user need not worry about preprocessing of
descriptors prior to model fitting.
Specifying model parameters with user.params
Sensible default values are selected for each tunable model parameter, however users may set any
parameter manually using the user.params argument.
MakeModelDefaults is a convenience function that makes a list containing the default parameters
for all models implemented in ModelTrain. Users may set any parameter manually by generating a
list with this function and modifying the parameters assigned to each modeling method:
params <- MakeModelDefaults(n = nrow(aid364),
p = ncol(aid364[, -c(1, 2)]), classify = TRUE, nfolds = 10)
params[1:3]
#> $NNet
#> size decay
#> 1 2 0
#>
#> $PCR
#> NULL
#>
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#> $ENet
#> lambda
#> 1 1
params$NNet$size <- 10
params[1:3]
#> $NNet
#> size decay
#> 1 10 0
#>
#> $PCR
#> NULL
#>
#> $ENet
#> lambda
#> 1 1
This list can then be provided to the user.params argument to assign the tuning parameter values
used by ModelTrain:
cml <- ModelTrain(USArrests, models = "NNet", nsplits = 3,
user.params = params)
Model assessment
Repeated k-fold cross-validation
For each descriptor set, ModelTrain performs repeated k-fold cross validation for the selected set of
regression and/or classification models.
For each cross-validation split, observations are randomly assigned to one of k folds, splitting the
data set into k blocks that are approximately equal in size. The number of cross validation folds (k) is
set with the nfolds argument. Users may also use the seed.in argument to set the seed for each split,
so that the ModelTrain results are reproducible. Each block is iteratively held out as a test set, while
the remaining k− 1 blocks are used to train each D-M combination. Predictions for the held out test
set are then made with the resulting models.
Many resampling methods for assessing model performance involve partitioning a data set into
a training set and test set. With these methods, predictions are made on observations that are not
involved in training. This results in model performance measures that are less likely to reward
over-fitting.
Since performance measures can be highly variable (James et al., 2013) depending on which
observations are held out and which are involved in training, the repetition of this procedure during
k-fold cross validation and the averaging of the performance measures often result in a more accurate
estimation of model performance than a one-time split.
Finding the right number of cross-validation folds for the estimation of a performance measure
involves consideration of the bias-variance trade off. The mean squared error of an estimator, a
measure of how accurately an estimator estimates the true value of a parameter, can be partitioned
into two components, bias and variance:
E[(θˆ − θ)2] = (E[θˆ]− θ)2 +Var[θˆ],
where θˆ is the estimator of the true performance measure, θ, for the population of test sets similar to
the data set under consideration. The first component is squared bias and the second is variance. An
increase in either the bias or variance will decrease the quality of an estimator. When a resampling
method substantially over- or under-estimates a performance measure on average, it is said to have
high bias. Bias is often related to size of the data set that is held out as a test set (James et al., 2013).
The smaller the number of folds in k-fold cross validation, the more observations are held out in each
fold, and the less observations that are used to train a model. Fewer observations in a training set
means that a model is likely to perform worse, and model predictions tend to miss the target. Thus,
performing k-fold cross validation with 2 folds, where there is 50% of the data in each fold, would
likely result in high bias.
In contrast, a performance measure estimator suffers from high variance when its estimate varies
considerably when there are slight changes made to the training and/or test set. Leave-One-Out-Cross-
CONTRIBUTED RESEARCH ARTICLE 7
Validation (LOOCV) refers to k-fold cross validation with k equal to n, the number of observations.
LOOCV often suffers from high variance (James et al., 2013). This is due to the fact that the training
set changes very little with each iteration of LOOCV. Thus, performance measure estimates tend be
highly positively correlated. The mean of a highly correlated variable has higher variance than an
uncorrelated one. Decreasing the number of folds tends to decrease the correlation of performance
measure estimates and lower the variance. Therefore, the ideal number of folds to use for cross
validation is often somewhere between 2 and n. The number of folds often used for k-fold cross
validation are 5 and 10, as these values frequently provide a good balance between bias and variance.
Several studies (Molinaro et al., 2005; Kim, 2009; Shen et al., 2011) have shown that repeated cross
validation can reduce the variance for a k-fold cross validation procedure with low bias, achieving
a more accurate estimation of model performance. When k-fold cross validation is repeated in
chemmodlab, multiple iterations of random fold assignment, or “splits”, are performed. Because the
observed performance measures may vary greatly depending on the definition of folds during k-fold
cross validation, all models are built using the same fold assignment, thus using fold definition as
a “blocking factor” in the assesment investigation. This process is repeated for multiple k-fold cross
validation runs. The user may choose the number of these splits with the nsplit argument.
There are a myriad of potential model violations that may lead to over- or under-estimation of
model accuracy measures. These include but are not limited to: a misspecification of the structural
form of the model (e.g., more descriptors, or a function of the descriptors should be used), correlation
between responses, measurement error in predictors, non-constant variance in the response, collinear-
ity between descriptors, and non-normality of the response. Also, the types of model violations that
occur in the training and test sets generated by k-fold cross validation may vary depending on how
the data is split, resulting in over- or under-estimation of a performance measure depending on how
the data was split. Since it is implausible to account for all model violations, our approach is to treat
the effect of model violation as a nuisance variable. By doing several random splits and averaging
the k-fold cross validated performance measures, we “average out” the model violation effect on the
performance measure estimate.
We will see later how, in addition to increased accuracy in estimation of performance measures,
repeated cross validation allows one to measure the standard error of model performance measures,
quantifying how sensitive performance measures are to fold assignments.
Accumulation curves
plot.chemmodlab takes a chemmodlab object output by the ModelTrain function and creates a series
of accumulation curve plots for assessing model performance.
The accumulation curve for binary responses shows the number of positives versus the number of
“tests” performed, where testing order is determined by the k-fold cross validated predicted probability
of a response being positive. The max.select argument sets the maximum number of tests to plot for
the accumulation curves. By default,
⌊
min(300, n4 )
⌋
is used, where n is the number of observations.
This prioritizes finding actives in a relatively small number of tests.
Two series of plots are constructed. In the “methods” series, there is one plot per CV split and
descriptor set combination. The accumulation curves for each modeling method are plotted together
so that they can be compared. In the “descriptors” plot series, there is one plot per CV split and model
fit. The accumulation curves for each descriptor set are plotted together so that they can be compared.
By default a large number of accumulation curve plots are constructed. The splits and meths
arguments may be used to only plot a subset of splits in the “methods” series of plots and methods in
the “descriptors” series of plots, respectively. The series argument specifies whether the “methods”
series of plots, the “descriptors” series of plots, or both are generated.
plot(cml, splits = 1, series = "descriptors")
plot(cml, splits = 1, meths = c("SVM", "RF"), series = "methods")
An “ideal” curve is plotted on these graphs to demonstrate the accumulation curve of a model
that correctly identifies the p positives in the first p tests. Thus, at m tests, models with accumulation
curves that are nearest to the ideal curve are preferable. Also, if an accumulation curve has a slope that
is parallel to the ideal curve for an interval of tests, the model has ideal performance for that interval.
A “random” curve shows the accumulation curve if the testing order were decided at random. At m
tests, models with accumulation curves that are below the random curve have worse performance
than random chance. Models that were fit as classification models (see “Model fitting: chemmodlab
models”) are represented as solid lines with different colors and shapes specifying the modeling
method. Models that were fit as continuous models and then thresholded are differentiated by line
type and color.
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Figure 2: Comparison of the first CV split accumulation curves for models fit to the Burden Numbers
descriptor set (top) and the Pharmacophore descriptor set (bottom)
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Figure 3: Comparison of the first CV split descriptor set accumulation curves for the SVM method
(top) and the RF method (bottom)
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In Figure 2, we have plotted the accumulation curves for the first CV split, generating two plots
in the “methods” series, one for each descriptor set. Comparing the accumulation curves for models
utilizing Burden Number descriptors, SVM and RF have much better hit rates than the other models for
the initial 100 compounds prioritized for testing. However, if more than 100 tests were to be performed,
the KNN method would have the best performance. Intersections between model accumulation curves
indicate the number of tests at which one model’s performance overtakes another’s. Considering
the Pharmacophore fingerprints, the RF method has ideal performance initially, but is eventually
superceded by the KNN method, as was the case for the Burden Number descriptors.
The next series of plots (Figure 3) is the “methods” series. When the Split 1 descriptor set
performances are compared for the SVM method, the Pharmacophore fingerprints have considerably
worse performance than the Burden Numbers. This is sensible as SVM performance often suffers
in high dimensional spaces. Comparing descriptor set performances for the RF method, the Burden
Number descriptors have slightly improved performance over the Pharmacophore fingerprints for
all but the initial few tests. However, at any number of tests at which Burden Numbers outperform
Pharmacophores, Burden Numbers only provide a few more hits. Therefore, it is plausible that if
this experiment were performed again with a different, but similar data set, Pharmacophores would
perform equally as well as Burden Numbers. One may be concerned about the statistical significance
of this improved performance. This observation has motivated the construction of the CombineSplits
function, which rigorously tests for statistically significant differences.
The accumulation curve has also been extended to continuous responses. In QSAR models, a
continuous response is often a measure of binding affinity (e.g., pKi) where a large positive value
is preferable. Therefore, in these accumulation curves, testing order is determined by ordering the
predicted response in decreasing order. The response is then accumulated so that ∑mi=1 yi is the sum of
the y over the first m tests. The binary response accumulation curve is a special case of this.
Multiple comparisons similarity plot
CombineSplits evaluates a specified performance measure across all splits. This function assesses
how sensitive performance measures are to fold assignments, or small changes to the training and test
sets. Intuitively, this assesses how much a performance measure may vary if predictions were made
on a test set that is similar to the data set analyzed. Multiplicity-adjusted statistical tests are used to
determine the best performing D-M combination.
As input, CombineSplits takes a chemmodlab object produced by the ModelTrain function.
CombineSplits can use many different performance measures to evaluate binary classification model
performance (namely: error rate, sensitivity, specificity, area under the receiver operating characteristic
curve, positive predictive value also known as precision, F1 measure, and initial enhancement). By
default, CombineSplits uses initial enhancement proposed by Kearsley et al. (1996) to assess model
performance. Initial enhancement at m tests is the hit rate – the fraction of accumulated positives at
m tests – divided by the proportion of positives in the entire data set. This is a measure of a model’s
hit rate fold improvement over random chance. A desirable model will have an initial enhancement
much larger than one. A typical number of tests for initial enhancement is m = 300.
CombineSplits(cml)
#> Analysis of Variance on: 'enhancement'
#> Using factors: Split and Descriptor/Method combination
#> Source DF SS MS F p-value
#> Model 19 72.5318 3.8175 22.8131 <.0001
#> Error 34 5.6894 0.1673
#> Total 53 78.2212
#> R-Square Coef Var Root MSE Mean
#> 0.9273 12.9890 0.4091 3.1494
#> Source DF SS MS F p-value
#> Split 2 1.463 0.732 4.372 0.0194
#> Desc/Meth 17 71.069 4.181 24.983 <.0001
An advantage of performing repeated k-fold cross validation with ModelTrain is that the output
can be viewed as a designed experiment with two factors: D-M combination and split (fold assignment).
Therefore, CombineSplits performs an analysis of variance (ANOVA) to identify significant differences
between the mean performance measures according to factor levels. The linear model corresponding
to this ANOVA is:
Yijk = µ+ αi + β j + eijk,
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Figure 4: MCS plot using initial enhancement at 300 tests as the performance measure.
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where αi corresponds to ith level of the split factor and β j to the jth level of the D-M combination factor.
From the ANOVA table in this example, the split main effect is marginally significant (p-value of
0.0194), indicating that there is a significant difference between mean initial enhancement across splits,
averaging over D-M combinations. In other words, some splits result in significantly larger initial
enhancement values than other splits. This endorses our decision to treat splits as a blocking factor.
The D-M combination main effect is highly significant (p-value < 0.0001). The “Error MS” estimates
the variance in the performance measures within the groups corresponding to each combination of
factor levels. The “Model MS” estimates the variance between groups.
The multiple comparisons similarity plot in Figure 4 shows the results for tests of significance
among all pairwise differences of mean model performance measures. Along both the x- and y-axes,
D-M combinations are ordered from best to worst performance measure. Because there can potentially
be a large number of methods (18 in the example leading to (182 ) = 153 pairwise comparisons), an
adjustment for multiple testing is necessary. We use the Tukey-Kramer multiple comparison procedure
(see Tukey and Berringer (1994) and Kramer (1956)).
In Figure 4, Burden Numbers-KNN, Burden Numbers-RF, Pharmacophore-KNN, and Burden
Numbers-SVM are the top performing models. We conclude that for the population of compounds
that are similar to the data set analyzed, the initial enhancement of these four models is plausibly the
same. The intuition is that if predictions were made on a new test set that is similar to the data set
under consideration, these four models would plausibly have very similar prediction performance.
There are different characteristics of the top performing models that may lead to a researcher
choosing one over the other. While KNN is not the most interpretable model, there are fast heuristic
KNN regression methods implemented in R such as FNN (Beygelzimer et al., 2013) that make pre-
dicting on large data sets more manageable. However RF has a time complexity comparable to the
fast heuristic KNN, and also results in a more interpretable model. Measures of variable importance
can be computed for RF, which allow users to identify the subset of variables that are most important
for prediction. The Burden Numbers-SVM model is the least interpretable of the set and has time
complexity that scales the worse with n (between O(n2) and O(n3) time complexity). Though the
Burden Numbers-KNN model is the best performing model according to mean initial enhancement,
this model performance measure is only .45 larger than the Burden Numbers-RF model and the
difference is not statistically significant. Since the Burden Numbers-RF model is more interpretable
and works just as well with large data, this modeling method may be preferrable.
The Pharmacophore-RF model is only significantly different from the best performing model at a
level between .01 and .05, but may be preferrable, as both the descriptor set and the model are highly
interpretable.
For many applications, users may know the number of tests they would like to perform. This is
often the case in drug discovery when chemists have a set number of compounds they would like to
assay and the goal is to enrich this set of compounds with as many actives as possible. The number of
tests used for initial enhancement may be modified with the m argument (Figure 5):
CombineSplits(cml, m = 100)
Figure 5 underscores the practical importance of using an appropriate number of tests for initial
enhancement. If a significance level of .05 were to be used, the Pharmacophore-KNN model is
no longer among the best performing models at m = 100, while the highly interpretable model,
Pharmacophore-RF, is now among the best. This model is the clear choice if an interpretable model is
desired.
These results support the observations regarding descriptor set accumulations curves for the RF
model in Figure 3. While there appeared to be a slight improvement using Burden Number descriptors
in lieu of Pharmacophore fingerprints, this improvement may not be considered statistically significant.
In this particular example, specificity does not do a good job at distinguishing the best performing
models, as the set of plausibly best performing models is quite large (Figure 6). This is due to the
fact that there are many models that have an average specificity that is similar to the best performing
model:
CombineSplits(cml, metric = "specificity")
Sensitivity, however, distinguishes the best performing model much better (Figure 7):
CombineSplits(cml, metric = "sensitivity")
For binary responses, model performance may also be assessed with misclassification rate (Figure
8). However, this measure may be inappropriate for drug discovery because it equally penalizes false
positives and false negatives. As we will explain in detail later on, researchers in cheminformatics
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Figure 5: MCS plot using initial enhancement at 100 tests as the performance measure.
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Figure 6: MCS plot using specificity for all compounds as the performance measure.
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Figure 7: MCS plot using sensitivity for all compounds as the performance measure.
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Figure 8: MCS plot using error rate for all compounds as the performance measure.
tend to be less concerned with false negatives and instead prioritize finding actives early. Therefore, a
meaure like intial enhanecement may be more appropriate.
CombineSplits(cml, metric = "error rate")
This example illustrates how using misclassification rate can be misleading if this is the only model
performance measure. Misclassification rate suggests several models (such as Pharmacophore-PLS
and Pharmacophore-LAR) are among the best performing models, but these models actually have
very low sensitivity (both .04). These models identify only a few of the 50 true positives in the data
set. If the goal of a medicinal chemist is to identify all of the active compounds in their data set, these
models may actually have poor performance.
It is also possible that models with high sensitivity incorrectly identify many compounds as active.
The positive predictive value (PPV), also known as precision, measures the percentage of compounds
that were correctly predicted to be active. PPV is an important means of evaluating search engines. A
search engine often finds a multitude of potentially relevant documents, but a user is only capable
of looking at the first few results. Search engines need to have very high PPV, even at the expense of
sensitivity and specificity (Brin and Page, 1998). The goal is not to correctly identify all the relevant
documents or all the irrelevant ones, but to identify the most relevant documents in the top few
results returned. In the context of drug discovery, testing potential drugs can be expensive and time
consuming. Medicinal chemists can only test a small proportion of the compounds in their data set, so
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Figure 9: MCS plot using PPV (precision) for all compounds as the performance measure.
the goal is to test compounds only when the certainty of activity is high. Therefore, models with low
PPV (i.e., a high false positive rate) may be less than ideal.
Figure 9 shows that the best performing models according to PPV (Pharmacophore-SVM, Pharmacophore-
RF, Pharmacophore-PLS, Burden Numbers-RF) all have a perfect PPV value – every compound
predicted to be active was indeed active.
CombineSplits(cml, metric = "ppv")
When a model has both high sensitivity and PPV, this means that many of the actives in the data
set were identified with a low number of false positives. The F1 measure strives to strike this balance
between sensitivity and PPV. It is the harmonic mean of sensitivity and PPV. Burden Numbers-SVM
and Burden Numbers-RF are the models which find the best balance, with Pharmacophore-RF being
only marginally significantly different (Figure 10).
CombineSplits(cml, metric = "fmeasure")
The area under the receiver operating characteristic curve (AUC) has also been implemented in
chemmodlab (Figure 1).
Table 1 summarizes the performance of the top performing D-M combinations over all performance
measures considered. Burden Numbers-RF and Burden Numbers-SVM are consistently the top
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Figure 10: MCS plot using F1 measure for all compounds as the performance measure.
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performers. However, if a significance level of .01 were used, Pharmacophore-RF would be a top
performer across all performance measures. The fact that Pharmacophore-RF is among the best models
for sensitivity and PPV but is marginally significantly different for AUC suggests that there may be a
threshold for the predicted probabilities other than .5 that will lead to better prediction performance
for Burden Numbers-RF and Burden Numbers-SVM. Conversely, the fact that Burden Numbers-SVM
is among the best for AUC but not for sensitivity or PPV suggests that a threshold other than .5 should
be used.
Descriptor Model IE 300 IE 100 Spec Sens Error Rate PPV F1 AUC
Burd RF X X X X X X X X
Burd SVM X X X X X X X
Phar RF X- X X X X X X- X-
Burd KNN X X X X X
Phar SVM X X X
Table 1: The best performing D-M combinations according to all performance measures considered.
Check indicates the D-M combination was among the best performers according to a performance mea-
sure using a significance level of 0.05. Check minus indicates marginal significant difference between
the D-M combination and the best performer (significance level between .01 and .05). Performance
measures considered were: initial enhancement at 300 tests, intial enhancement at 100 tests, specificity,
sensitivity, error rate, posterior predictive value, F1 measure, and area under the receiver operating
characteristic curve.
Several performance measures have been included for continuous responses. Though root mean
squared error (RMSE) is used broadly in statistics, it may not be suitable for continuous chemical assay
responses used in cheminformatics. This is because under-predicting and over-predicting biological
activity is equally penalized. An appropriate alternative may be initial enhancement. Other options
are the coefficient of determination (R2) and Spearman’s ρ.
Conclusions and future directions
chemmodlab provides a comprehensive collection of methods for fitting and assessing machine
learning models. While these methods have been selected for their utility to the cheminformatics
community, they can be applied to any data set with binary or continuous variables. These methods
are applicable to a wide range of research areas, and some model assessment approaches (the MCS
plot, continuous valued accumulation curves) are novel additions to the assessment of the machine
learning methods available in R. The functions in chemmodlab aim to enable researchers to try many
different model fitting and assessment procedures with ease.
chemmodlab has many future directions in store. Parallel processing will be utilized so that
model fitting for different descriptor sets, splits, and cross validation folds can be done in parallel. We
also plan to interface chemmodlab with caret, employing their functions for model tuning during
our model fitting procedure. Support for categorical variables with more than two levels will be
arriving soon. We will also incoporate more extensions to the accumulation curve as this approach is
used extensively in drug discovery. Extensions will include the area under the accumulation curve
as an assessment measure and the construction of a mean accumulation curve over multiple splits.
Error bars can be plotted for these curves so that significant differences between D-M combinations
can be analyzed across the entire curves. Additional graphical output is planned, e.g., to provide
receiver operating characteristic curves and precision recall curves along with accumulation curves,
per user request. Finally, more modeling methods will be added as we identify those with appeal to
our user base. Support for a particular model may be requested here: https://github.com/jrash/
chemmodlab/issues.
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